The Insurtech sector in Q2 2025 showcased a dynamic interplay of resilience and adaptation, as detailed in the CB Insights Insurtech report.
Despite a persistent decline in deal volume, global insurtech funding surged to $1.6 billion, marking a 23% quarter-over-quarter (QoQ) increase and the strongest quarterly performance since Q1 2023.
This rebound, driven by a handful of significant deals and a growing focus on artificial intelligence (AI), underscores the sector’s evolving landscape amid broader venture capital challenges.
However, with deal counts dropping to an 8-year low of 77, the industry faces hurdles that could shape its development pipeline for years to come.
Global insurtech funding in Q2 2025 reached $1.6 billion, a notable recovery from the $1.3 billion recorded in Q1 2025.
This growth outpaced the broader venture capital market, which saw only a 3% QoQ increase, and contrasted sharply with fintech’s 11% QoQ decline.
The surge was propelled by a few high-profile deals, particularly in AI-driven insurtechs.
For instance, hyperexponential, a London-based AI-powered pricing platform, raised a $73 million Series B round, signaling strong investor confidence in specialized AI applications.
Similarly, Akur8, another AI-powered pricing platform, secured significant funding, reflecting the market’s appetite for technologies that enhance underwriting and risk assessment.
These deals highlight AI’s transformative role in reshaping the insurance value chain, from claims processing to personalized pricing.
AI’s dominance is not limited to startups.
Established insurers are increasingly integrating generative AI (genAI) to streamline operations and improve customer experiences.
CB Insights notes that AI capabilities are becoming a competitive necessity, with both 100-day-old startups and century-old incumbents adapting to this new reality.
This trend aligns with the broader venture environment, where AI funding has skyrocketed—OpenAI alone raised nearly 31 times the total insurtech funding in Q1 2025.
Insurtechs leveraging AI, such as Assured, which achieved unicorn status with a $1 billion valuation in Q1 2025, are at the forefront of this shift, focusing on genAI-driven claims platforms and hiring talent to bolster innovation.
Despite the funding uptick, deal count plummeted to 77 in Q2 2025, a 42% year-over-year (YoY) decline and the lowest since Q2 2016.
This contraction mirrors a broader venture capital slowdown but is particularly stark in insurtech, where investor caution has led to fewer but larger deals.
The median insurtech deal size rose to $5 million in 2024 year-to-date (YTD), a 25% increase from 2023, driven by a record-high median early-stage deal size of $4 million.
However, late-stage deal sizes dropped to $31 million, the lowest since 2018, indicating a shift toward early-stage investments.
This focus on early-stage deals reflects investor optimism about emerging insurtechs with strong fundamentals.
For example, fertility-focused platform Gaia raised a $15 million Series A in Q1 2025, one of the largest early-stage deals.
Meanwhile, late-stage insurtechs showed sluggish growth, with median headcount increases of just 3% over the past year, compared to 20% for recently funded startups.
This suggests investors are prioritizing scalable, tech-driven models over mature companies with slower growth trajectories.
Geographically, Silicon Valley’s influence waned, with its share of global insurtech funding dropping to 10% in 2024 from 20% in 2023, surpassed by New York at 15%.
Europe, however, solidified its position, capturing a record 35% of deal share in Q2 2024, driven by deals like hyperexponential’s and ELEMENT’s $54 million Series C.
M&A activity also picked up, with notable acquisitions signaling strategic moves by incumbents to secure innovative tech amid declining valuations.
The sustained drop in early-stage funding—down 35% YoY to $179 million in Q1 2025—raises concerns about the industry’s development pipeline.
Smaller check sizes could provide opportunities for incumbents to partner with capital-constrained startups, securing favorable terms and early access to cutting-edge tech.
However, the competitive landscape is intensifying, with AI-driven insurtechs like Assured setting the pace.
Insurance executives must act swiftly to build relationships with promising startups to stay ahead in a market increasingly defined by technological disruption.
In conclusion, Q2 2025 paints a complex picture for insurtech: a funding rebound fueled by AI enthusiasm, tempered by a historic low in deal volume.
As the sector navigates these challenges, the integration of AI and strategic partnerships will likely define its path forward, balancing product development with market consolidation.